[CALT] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
26-Apr-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 59.59%
YoY- 98.32%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 294,592 269,384 191,352 429,042 260,056 64,047 49,734 227.02%
PBT -164,082 -70,660 -208,019 10,066 -15,958 -192,090 -211,434 -15.53%
Tax 4,276 21,274 -20,494 13,747 -6,848 339 -4,387 -
NP -168,357 -91,934 -187,525 -3,681 -9,110 -192,429 -207,047 -12.87%
Tax Rate - - - -136.57% - - - -
Total Cost 462,949 361,318 378,877 432,723 269,166 256,476 256,781 48.07%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -57.15 -34.13 -98.00 -0.86 -3.50 -300.45 -416.31 -73.35%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -3.14 -1.71 -3.49 -0.07 -0.34 -7.24 -7.91 -45.95%
EPS Diluted -3.14 -1.71 -3.49 -0.07 -0.34 -7.24 -7.91 -45.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.